The critical role of carboxy-terminal amino acids in ligand-dependent and -independent transactivation of the constitutive androstane receptor

被引:31
作者
Andersin, T [1 ]
Väisänen, S [1 ]
Carlberg, C [1 ]
机构
[1] Univ Kuopio, Dept Biochem, FIN-70211 Kuopio, Finland
关键词
D O I
10.1210/me.2002-0263
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The mouse constitutive androstane receptor (CAR) is a unique member of the nuclear receptor superfamily, for which an inverse agonist, the testosterone metabolite 5alpha-androstan-3alpha-ol (androstanol), and an agonist, the xenobiotic 1,4-bis[2-(3, 5-dichloropyridyloxy)] benzene, are known. In this study the role of the transactivation domain 2 (AF-2) of CAR was investigated, which is formed by the seven most carboxy-terminal amino acids of the receptor. The AF-2 domain was shown to be critical for the constitutive activity by mediating a ligand-independent interaction of CAR with coactivator (CoA) proteins. In addition this domain increased and decreased contact with CoAs in the presence of agonist and inverse agonist, respectively. In analogy to classical endocrine nuclear receptors, in CAR the charge clamp between K187 (in helix 3) and E355 (within the AF-2 domain) was expected to be critical for its interaction with CoAs. However, the hydrophobic amino acids L352, L353, and 1356 on the surface of the AF-2 domain were found to be more important for this protein-protein interaction. Moreover, these amino acids and C357 were shown to be involved in the response of CAR to androstanol. Interestingly, the cysteine at position 357 appears to block classical endocrine responsiveness of CAR to agonists, since mutagenesis of this amino acid both reduced CoA interaction in the absence of ligand and drastically increased inducibility by 1,4-bis[2-(3, 5-dichloropyridyloxy)] benzene. We showed that this blockade is not due to an intramolecular disulfide bridge, but is probably caused by an interaction between C357 and Y336.
引用
收藏
页码:234 / 246
页数:13
相关论文
共 39 条
[1]   A NEW ORPHAN MEMBER OF THE NUCLEAR HORMONE-RECEPTOR SUPERFAMILY THAT INTERACTS WITH A SUBSET OF RETINOIC ACID RESPONSE ELEMENTS [J].
BAES, M ;
GULICK, T ;
CHOI, HS ;
MARTINOLI, MG ;
SIMHA, D ;
MOORE, DD .
MOLECULAR AND CELLULAR BIOLOGY, 1994, 14 (03) :1544-1552
[2]   CLONING AND EXPRESSION OF FULL-LENGTH CDNA-ENCODING HUMAN VITAMIN-D RECEPTOR [J].
BAKER, AR ;
MCDONNELL, DP ;
HUGHES, M ;
CRISP, TM ;
MANGELSDORF, DJ ;
HAUSSLER, MR ;
PIKE, JW ;
SHINE, J ;
OMALLEY, BW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (10) :3294-3298
[3]   MECHANISMS OF NUCLEAR SIGNALING BY VITAMIN-D-3 - INTERPLAY WITH RETINOID AND THYROID-HORMONE SIGNALING [J].
CARLBERG, C .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1995, 231 (03) :517-527
[4]   Nuclear receptors and lipid physiology: Opening the X-files [J].
Chawla, A ;
Repa, JJ ;
Evans, RM ;
Mangelsdorf, DJ .
SCIENCE, 2001, 294 (5548) :1866-1870
[5]   Differential transactivation by two isoforms of the orphan nuclear hormone receptor CAR [J].
Choi, HS ;
Chung, MR ;
Tzameli, I ;
Simha, D ;
Lee, YK ;
Seol, W ;
Moore, DD .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (38) :23565-23571
[6]   ACTIVATION FUNCTION-2 (AF-2) OF RETINOIC ACID RECEPTOR AND 9-CIS RETINOIC ACID RECEPTOR - PRESENCE OF A CONSERVED AUTONOMOUS CONSTITUTIVE ACTIVATING DOMAIN AND INFLUENCE OF THE NATURE OF THE RESPONSE ELEMENT ON AF-2 ACTIVITY [J].
DURAND, B ;
SAUNDERS, M ;
GAUDON, C ;
ROY, B ;
LOSSON, R ;
CHAMBON, P .
EMBO JOURNAL, 1994, 13 (22) :5370-5382
[7]   A structural model of the constitutive androstane receptor defines novel interactions that mediate ligand-independent activity [J].
Dussault, I ;
Lin, M ;
Hollister, K ;
Fan, M ;
Termini, J ;
Sherman, MA ;
Forman, BM .
MOLECULAR AND CELLULAR BIOLOGY, 2002, 22 (15) :5270-5280
[8]   Hormone-dependent coactivator binding to a hydrophobic cleft on nuclear receptors [J].
Feng, WJ ;
Ribeiro, RCJ ;
Wagner, RL ;
Nguyen, H ;
Apriletti, JW ;
Fletterick, RJ ;
Baxter, JD ;
Kushner, PJ ;
West, BL .
SCIENCE, 1998, 280 (5370) :1747-1749
[9]   Androstane metabolites bind to and deactivate the nuclear receptor CAR-β [J].
Forman, BM ;
Tzameli, I ;
Choi, HS ;
Chen, L ;
Simha, D ;
Seol, W ;
Evans, RM ;
Moore, DD .
NATURE, 1998, 395 (6702) :612-615
[10]   Asymmetry in the PPARγ/RXRα crystal structure reveals the molecular basis of heterodimerization among nuclear receptors [J].
Gampe, RT ;
Montana, VG ;
Lambert, MH ;
Miller, AB ;
Bledsoe, RK ;
Milburn, MV ;
Kliewer, SA ;
Willson, TM ;
Xu, HE .
MOLECULAR CELL, 2000, 5 (03) :545-555